Asia Pacific Joint Pain Injections Market Size, Share & Industry Trends Analysis Report By Injection Type (Interleukin Inhibitors, Hyaluronic Acid Injections), By Distribution Channel, By Joint Type Channel, By Country and Growth Forecast, 2022

List of Tables

The Asia Pacific Joint Pain Injections Market would witness market growth of 8.6% CAGR during the forecast period (2022-2028).

Injections are useful because they can momentarily lessen swelling and pain in inflamed joints. Therapeutic joint injections are minimally invasive, target the afflicted area directly, and provide localized relief with few to no adverse effects. Joint injections are frequently advised for patients seeking long-term relief from pain that does not improve with more traditional therapies, such as oral anti-inflammatory drugs. Most people have pain reduction after a peripheral intra-articular injection for two to six months.

Injections can reduce pain and inflammation to a sufficient degree to allow other treatments for the underlying problem to be used, even though they do not treat the condition that causes joint pain. Physical treatment helps strengthen muscles and improve mobility in the afflicted joint, enhancing the positive benefits of joint injections. Physical therapy sessions could be advised in addition to a period of joint rest. In order to enhance the biomechanics of a joint, patients may also be encouraged to undertake lifestyle adjustments, such as decreasing weight or switching up their footwear. The goal is to limit or eliminate the need for additional injections by including joint injections in a more comprehensive therapeutic strategy.

China has one of the world's fastest-aging populations. By 2040, 28% of the population of China is projected to be over 60 due to increased life expectancy and declining birth rates. This significant population change presents new opportunities and difficulties for socioeconomic growth and public health. Therefore, developing an integrated system that addresses the social and medical requirements of the elderly while guaranteeing universal access to healthcare, regardless of location, is particularly crucial. The prevalence of illnesses calling for joint pain injections may increase as the population becomes older. As a result, the Asia Pacific region's market for joint pain injections might expand.

The China market dominated the Asia Pacific Joint Pain Injections Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $717.6 Million by 2028. The Japan market is registering a CAGR of 7.9% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 9.2% during (2022 - 2028).

Based on Injection Type, the market is segmented into Interleukin Inhibitors, Hyaluronic Acid Injections, and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Joint Type Channel, the market is segmented into Knee & Ankle, Shoulder & Elbow, Hip Joint, Facet Joints of the Spine, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bioventus Inc., Pacira BioSciences, Inc., AbbVie, Inc., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc., Anika Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Eli Lilly And Company, Ferring Holdings SA, and Sanofi S.A.

Scope of the Study

Market Segments covered in the Report:

By Injection Type

Interleukin Inhibitors
Hyaluronic Acid Injections
Others

By Distribution Channel

Drug Stores & Retail Pharmacies
Hospital Pharmacies
Others

By Joint Type

Knee & Ankle
Shoulder & Elbow
Hip Joint
Facet Joints of the Spine
Others

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Companies Profiled

Bioventus Inc.
Pacira BioSciences, Inc.
AbbVie, Inc.
Teva Pharmaceuticals Industries Ltd.
Pfizer, Inc.
Anika Therapeutics, Inc.
Zimmer Biomet Holdings, Inc.
Eli Lilly And Company
Ferring Holdings SA
Sanofi S.A.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Joint Pain Injections Market, by Injection Type
- 1.4.2 Asia Pacific Joint Pain Injections Market, by Distribution Channel
- 1.4.3 Asia Pacific Joint Pain Injections Market, by Joint Type
- 1.4.4 Asia Pacific Joint Pain Injections Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Asia Pacific Joint Pain Injections Market by Injection Type

3.1 Asia Pacific Interleukin Inhibitors Market by Country
3.2 Asia Pacific Hyaluronic Acid Injections Market by Country
3.3 Asia Pacific Others Market by Country

Chapter 4. Asia Pacific Joint Pain Injections Market by Distribution Channel

4.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
4.2 Asia Pacific Hospital Pharmacies Market by Country
4.3 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Joint Pain Injections Market by Joint Type

5.1 Asia Pacific Knee & Ankle Market by Country
5.2 Asia Pacific Shoulder & Elbow Market by Country
5.3 Asia Pacific Hip Joint Market by Country
5.4 Asia Pacific Facet Joints of the Spine Market by Country
5.5 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Joint Pain Injections Market by Country

6.1 China Joint Pain Injections Market
- 6.1.1 China Joint Pain Injections Market by Injection Type
- 6.1.2 China Joint Pain Injections Market by Distribution Channel
- 6.1.3 China Joint Pain Injections Market by Joint Type
6.2 Japan Joint Pain Injections Market
- 6.2.1 Japan Joint Pain Injections Market by Injection Type
- 6.2.2 Japan Joint Pain Injections Market by Distribution Channel
- 6.2.3 Japan Joint Pain Injections Market by Joint Type
6.3 India Joint Pain Injections Market
- 6.3.1 India Joint Pain Injections Market by Injection Type
- 6.3.2 India Joint Pain Injections Market by Distribution Channel
- 6.3.3 India Joint Pain Injections Market by Joint Type
6.4 South Korea Joint Pain Injections Market
- 6.4.1 South Korea Joint Pain Injections Market by Injection Type
- 6.4.2 South Korea Joint Pain Injections Market by Distribution Channel
- 6.4.3 South Korea Joint Pain Injections Market by Joint Type
6.5 Singapore Joint Pain Injections Market
- 6.5.1 Singapore Joint Pain Injections Market by Injection Type
- 6.5.2 Singapore Joint Pain Injections Market by Distribution Channel
- 6.5.3 Singapore Joint Pain Injections Market by Joint Type
6.6 Malaysia Joint Pain Injections Market
- 6.6.1 Malaysia Joint Pain Injections Market by Injection Type
- 6.6.2 Malaysia Joint Pain Injections Market by Distribution Channel
- 6.6.3 Malaysia Joint Pain Injections Market by Joint Type
6.7 Rest of Asia Pacific Joint Pain Injections Market
- 6.7.1 Rest of Asia Pacific Joint Pain Injections Market by Injection Type
- 6.7.2 Rest of Asia Pacific Joint Pain Injections Market by Distribution Channel
- 6.7.3 Rest of Asia Pacific Joint Pain Injections Market by Joint Type

Chapter 7. Company Profiles

7.1 Bioventus Inc.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Regional Analysis
- 7.1.4 Research & Development Expenses
- 7.1.5 Recent strategies and developments:
  - 7.1.5.1 Product Launches and Product Expansions:
7.2 Pacira BioSciences, Inc.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Research & Development Expenses
- 7.2.4 Recent strategies and developments:
  - 7.2.4.1 Acquisition and Mergers:
7.3 AbbVie, Inc.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 Recent strategies and developments:
  - 7.3.5.1 Trails and Approvals:
7.4 Teva Pharmaceutical Industries Ltd.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional Analysis
- 7.4.4 Research & Development Expenses
7.5 Pfizer, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Regional & Segmental Analysis
- 7.5.4 Research & Development Expense
7.6 Anika Therapeutics, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional Analysis
- 7.6.4 Research & Development Expenses
7.7 Zimmer Biomet Holdings, Inc.
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Regional Analysis
- 7.7.4 Research & Development Expense
7.8 Eli Lilly And Company
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expenses
7.9 Ferring Holdings SA
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Regional Analysis
- 7.9.4 Research and Development Expense
7.10. Sanofi S.A.
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Segmental and Regional Analysis
- 7.10.4 Research & Development Expense

LIST OF TABLES

TABLE 1 Asia Pacific Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Interleukin Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Interleukin Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Hyaluronic Acid Injections Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Hyaluronic Acid Injections Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Knee & Ankle Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Knee & Ankle Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Shoulder & Elbow Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Shoulder & Elbow Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Hip Joint Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Hip Joint Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Facet Joints of the Spine Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Facet Joints of the Spine Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Joint Pain Injections Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Joint Pain Injections Market by Country, 2022 - 2028, USD Million
TABLE 33 China Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 34 China Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 35 China Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 36 China Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 37 China Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 38 China Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 39 China Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 40 China Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 41 Japan Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 42 Japan Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 43 Japan Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 44 Japan Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 45 Japan Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 46 Japan Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 47 Japan Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 48 Japan Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 49 India Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 50 India Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 51 India Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 52 India Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 53 India Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 54 India Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 55 India Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 56 India Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 57 South Korea Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 58 South Korea Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 59 South Korea Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 60 South Korea Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 61 South Korea Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 62 South Korea Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 63 South Korea Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 64 South Korea Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 65 Singapore Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 66 Singapore Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 67 Singapore Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 68 Singapore Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 69 Singapore Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 70 Singapore Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 71 Singapore Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 72 Singapore Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 73 Malaysia Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 74 Malaysia Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 75 Malaysia Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 76 Malaysia Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 77 Malaysia Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 78 Malaysia Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 79 Malaysia Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 80 Malaysia Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 81 Rest of Asia Pacific Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 82 Rest of Asia Pacific Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 83 Rest of Asia Pacific Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 84 Rest of Asia Pacific Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 85 Rest of Asia Pacific Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 86 Rest of Asia Pacific Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 87 Rest of Asia Pacific Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 88 Rest of Asia Pacific Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 89 Key Information - Bioventus Inc.
TABLE 90 Key Information - Pacira BioSciences, Inc.
TABLE 91 Key information - AbbVie, Inc.
TABLE 92 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 93 Key Information - Pfizer, Inc.
TABLE 94 Key Information - Anika Therapeutics, Inc.
TABLE 95 key Information - Zimmer Biomet Holdings, Inc.
TABLE 96 Key Information - Eli Lilly And Company
TABLE 97 key information - Ferring Holdings SA
TABLE 98 Key Information - Sanofi S.A.

List of Figures

FIG 1 Methodology for the research

Asia Pacific Joint Pain Injections Market Size, Share & Industry Trends Analysis Report By Injection Type (Interleukin Inhibitors, Hyaluronic Acid Injections), By Distribution Channel, By Joint Type Channel, By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents